{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:21:11Z","timestamp":1791238871425,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T00:00:00Z","timestamp":1295913600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1000398","type":"journal-article","created":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T15:26:05Z","timestamp":1295969165000},"page":"e1000398","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":211,"title":["A Research Agenda for Malaria Eradication: Vaccines"],"prefix":"10.1371","volume":"8","author":[{"name":"The malERA Consultative Group on Vaccines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"ref1","first-page":"535","article-title":"Principles and lessons from the smallpox eradication programme.","volume":"65","author":"DA Henderson","year":"1987","journal-title":"Bull World Health Organ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.8.1.5","article-title":"Role of injectable and oral polio vaccines in polio eradication.","volume":"8","author":"J John","year":"2009","journal-title":"Expert Rev Vaccines Jan"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nrmicro1550","article-title":"Global measles elimination.","volume":"12","author":"WJ Moss","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e1000405","DOI":"10.1371\/journal.pmed.1000405","article-title":"The role of research in viral disease eradication and elimination programs: Lessons for malaria eradication.","volume":"8","author":"JG Breman","year":"2011","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)61261-6","article-title":"Maternal and neonatal tetanus.","volume":"370","author":"MH Roper","year":"2007","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(05)66788-8","article-title":"Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: A prospective study.","volume":"366","author":"RA Adegbola","year":"2005","journal-title":"Lancet"},{"key":"ref7","year":"2006"},{"key":"ref8","year":"2000"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/S0264-410X(00)00521-1","article-title":"Transmission blocking malaria vaccines.","volume":"19","author":"R Carter","year":"2001","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(00)02516-2","article-title":"DDT house spraying and re-emerging malaria.","volume":"356","author":"DR Roberts","year":"2000","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(08)61655-4","article-title":"Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya.","volume":"372","author":"WP O'Meara","year":"2008","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(08)61654-2","article-title":"Changes in malaria indices between 1999 and 2007 in The Gambia: A retrospective analysis.","volume":"372","author":"SJ Ceesay","year":"2008","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of <italic>Plasmodium vivax<\/italic> malaria.","volume":"64","author":"K Mendis","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4269\/ajtmh.2009.80.194","article-title":"Severe <italic>Plasmodium vivax<\/italic> malaria: A report on serial cases from Bikaner in northwestern India.","volume":"80","author":"DK Kochar","year":"2009","journal-title":"Am J Trop Med Hyg Feb"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3201\/eid1101.040519","article-title":"<italic>Plasmodium vivax<\/italic> malaria.","volume":"11","author":"DK Kochar","year":"2005","journal-title":"Emerg Infect Dis Jan"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","article-title":"Vivax malaria: Neglected and not benign.","volume":"77","author":"RN Price","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/QCO.0b013e32832f14c1","article-title":"New developments in <italic>Plasmodium vivax<\/italic> malaria: Severe disease and the rise of chloroquine resistance.","volume":"22","author":"RN Price","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1000399","DOI":"10.1371\/journal.pmed.1000399","article-title":"A research agenda for malaria eradication: Basic science and enabling technologies.","volume":"8","year":"2011","journal-title":"PLoS Med"},{"key":"ref19","first-page":"1125","article-title":"<italic>Plasmodium knowlesi<\/italic> from archival blood films: Further evidence that human infections are widely distributed and not newly emergent in Malaysian Borneo.","volume":"9","author":"KS Lee","year":"2009","journal-title":"Int J Parasitol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/524888","article-title":"<italic>Plasmodium knowlesi<\/italic> malaria in humans is widely distributed and potentially life threatening.","volume":"46","author":"J Cox-Singh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pt.2008.01.004","article-title":"Sex in <italic>Plasmodium<\/italic>: A sign of commitment.","volume":"24","author":"MW Dixon","year":"2008","journal-title":"Trends Parasitol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1000402","DOI":"10.1371\/journal.pmed.1000402","article-title":"A research agenda for malaria eradication: Drugs.","volume":"8","year":"2011","journal-title":"PLoS Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: A transmission blocking vaccine for <italic>Plasmodium vivax<\/italic> malaria.","volume":"23","author":"EM Malkin","year":"2005","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.","volume":"3","author":"Y Wu","year":"2008","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1073\/pnas.0800459105","article-title":"Correctly folded Pfs48\/45 protein of <italic>Plasmodium falciparum<\/italic> elicits malaria transmission-blocking immunity in mice.","volume":"105","author":"NS Outchkourov","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e6352","DOI":"10.1371\/journal.pone.0006352","article-title":"A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48\/45 expressed in <italic>Escherichia coli<\/italic>.","volume":"4","author":"DR Chowdhury","year":"2009","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against <italic>Plasmodium falciparum<\/italic> infection and disease in young African children: Randomised controlled trial.","volume":"364","author":"PL Alonso","year":"2004","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of <italic>Plasmodium falciparum<\/italic> disease in Mozambican children: Single-blind extended follow-up of a randomised controlled trial.","volume":"366","author":"PL Alonso","year":"2005","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating sporozoite vaccine to prevent <italic>Plasmodium falciparum<\/italic> malaria.","volume":"6","author":"SL Hoffman","year":"2010","journal-title":"Hum Vaccin"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating sporozoite vaccine to prevent <italic>Plasmodium falciparum<\/italic> malaria.","volume":"6","author":"M Pinder","year":"2010","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1073\/pnas.0702239104","article-title":"Disruption of <italic>Plasmodium falciparum<\/italic> development by antibodies against a conserved mosquito midgut antigen.","volume":"104","author":"RR Dinglasan","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1000401","DOI":"10.1371\/journal.pmed.1000401","article-title":"A research agenda for malaria eradication: Vector control.","volume":"8","year":"2011","journal-title":"PLoS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm785","article-title":"Migration through host cells activates <italic>Plasmodium<\/italic> sporozoites for infection.","volume":"8","author":"MM Mota","year":"2002","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(00)80511-5","article-title":"TRAP is necessary for gliding motility and infectivity of <italic>Plasmodium<\/italic> sporozoites.","volume":"90","author":"AA Sultan","year":"1997","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(92)90251-7","article-title":"The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of <italic>Plasmodium falciparum<\/italic> sporozoites.","volume":"70","author":"C Cerami","year":"1992","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"47613","DOI":"10.1074\/jbc.M208453200","article-title":"Function of region I and II adhesive motifs of <italic>Plasmodium falciparum<\/italic> circumsporozoite protein in sporozoite motility and infectivity.","volume":"277","author":"R Tewari","year":"2002","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1093\/emboj\/18.19.5195","article-title":"The A-domain and the thrombospondin-related motif of <italic>Plasmodium falciparum<\/italic> TRAP are implicated in the invasion process of mosquito salivary glands.","volume":"18","author":"K Wengelnik","year":"1999","journal-title":"EMBO J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/IAI.68.4.1964-1966.2000","article-title":"Antibodies against the <italic>Plasmodium falciparum<\/italic> receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids.","volume":"68","author":"DL Narum","year":"2000","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0166-6851(02)00122-6","article-title":"Bacterially expressed and refolded receptor binding domain of <italic>Plasmodium falciparum<\/italic> EBA-175 elicits invasion inhibitory antibodies.","volume":"123","author":"KC Pandey","year":"2002","journal-title":"Mol Biochem Parasitol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.vaccine.2006.09.048","article-title":"Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of <italic>Plasmodium falciparum<\/italic> EBA-175.","volume":"25","author":"P Pattnaik","year":"2007","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1126\/science.8009226","article-title":"Receptor and ligand domains for invasion of erythrocytes by <italic>Plasmodium falciparum<\/italic>.","volume":"264","author":"BK Sim","year":"1994","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1371\/journal.pmed.0040337","article-title":"<italic>Plasmodium vivax<\/italic> invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.","volume":"4","author":"BT Grimberg","year":"2007","journal-title":"PLoS Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e1000104","DOI":"10.1371\/journal.ppat.1000104","article-title":"Antibodies targeting the PfRH1 binding domain inhibit invasion of <italic>Plasmodium falciparum<\/italic> merozoites.","volume":"4","author":"X Gao","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nm.1850","article-title":"Effective induction of high-titer antibodies by viral vector vaccines.","volume":"14","author":"SJ Draper","year":"2008","journal-title":"Nat Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-3024.2009.01138.x","article-title":"Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming \u2018vaccine resistant malaria\u2019.","volume":"31","author":"SL Takala","year":"2009","journal-title":"Parasite Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e1000404","DOI":"10.1371\/journal.pmed.1000404","article-title":"A research agenda for malaria eradication: Cross cutting issues for eradication.","volume":"8","year":"2011","journal-title":"PLoS"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e1000400","DOI":"10.1371\/journal.pmed.1000400","article-title":"A research agenda for malaria eradication: Monitoring, evaluation, and surveillance.","volume":"8","year":"2011","journal-title":"PLoS"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/503051","article-title":"Moderate effect of artemisinin-based combination therapy on transmission of <italic>Plasmodium falciparum<\/italic>.","volume":"193","author":"JT Bousema","year":"2006","journal-title":"J Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S0031182004006067","article-title":"Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data.","volume":"130","author":"M van der Kolk","year":"2005","journal-title":"Parasitology"},{"key":"ref50","article-title":"Guidelines for the evaluation of <italic>Plasmodium falciparum<\/italic> vaccines in populations exposed to natural infection.","year":"1997"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e3193","DOI":"10.1371\/journal.pone.0003193","article-title":"What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines.","volume":"3","author":"MA Penny","year":"2008","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e1000403","DOI":"10.1371\/journal.pmed.1000403","article-title":"A research agenda for malaria eradication: Modeling.","volume":"8","year":"2011","journal-title":"PLoS"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e1000396","DOI":"10.1371\/journal.pmed.1000396","article-title":"A research agenda for malaria eradication: Diagnoses and diagnostics.","volume":"8","year":"2011","journal-title":"PLoS"},{"key":"ref54","year":"2000"},{"key":"ref55","year":"2006"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1000398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T14:57:29Z","timestamp":1588949849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1000398","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,25]]}}}